Pfizer and Moderna set to adapt to Omicron COVID variant
The manufacturers of America’s most used COVID-19 vaccines insist they have plans in place to quickly adapt to potential challenges presented by the new omicron variant.
News, articles, comments, with a minute-by-minute update, now on Today24.pro
Today24.pro — latest news 24/7. You can add your news instantly now — here